Noor Ul Ain Rehman

Contributing Author

Recent Articles by Noor Ul Ain Rehman

Jul-22	Gryphon Digital Mining (GRYP) Enters Into a Definitive Merger Agreement With American Bitcoin Corp. GRYP Insider Monkey
Jul-22	Noble Financial Maintains a Buy on Bit Digital (BTBT), Sets a PT of $5.50 BTBT Insider Monkey
Jul-22	H.C. Wainwright Reiterates a Buy Rating on HIVE Digital Technologies (HIVE), Sets a $6 PT HIVE Insider Monkey
Jul-22	B. Riley Initiates Coverage of BitFuFu (FUFU) with a Buy Rating FUFU Insider Monkey
Jul-22	Bitfarms (BITF) Finalizes Share Purchase Agreement Regarding Paraguay Mining Site BITF Insider Monkey
Jul-22	Canaan (CAN) to Produce Around 6,840 Avalon A15Pro Miners for Cipher Mining CAN Insider Monkey
Jul-22	Two Prime Announces $20 Million Equity Investment Led by Marathon Digital Holdings (MARA) MARA Insider Monkey
Jul-22	Northland Securities Maintains a Buy Rating on Bitdeer Technologies (BTDR), Sets a $20 Price Target BTDR Insider Monkey
Jul-22	B. Riley Initiates Coverage of CleanSpark (CLSK) With a Buy Rating CLSK Insider Monkey
Jul-22	BTIG Maintains a Buy on Iris Energy (IREN), Sets a PT of $22 IREN Insider Monkey
Jul-22	BTIG Remains Bullish on Riot Platforms (RIOT) RIOT Insider Monkey
Jul-22	TeraWulf (WULF) Gets Initiated With a Market Outperform Rating at JMP Securities WULF Insider Monkey
Jul-22	Citizens JMP Downgrades Core Scientific (CORZ) to Market Perform From Outperform CORZ Insider Monkey
Jul-22	Cipher Mining's (CIFR) Black Pearl Phase I Surpasses Guidance, Reaches a Self-Mining Capacity of Around 3.4 EH/s CIFR Insider Monkey
Jul-22	Barclays Downgrades BRF S.A. (BRFS) to Equal Weight from Overweight BRFS Insider Monkey
Jul-22	Scotiabank Lowers PT on Gerdau S.A. (GGB) to R$20 From R$31, Keeps a Sector Perform Rating GGB Insider Monkey
Jul-22	SEB Equities Upgrades Borr Drilling (BORR) to Hold From Sell, Keeps a $1.90 PT BORR Insider Monkey
Jul-22	UBS Maintains a Hold on Ambev S.A. (ABEV), Sets a Price Target of $2.50 ABEV Insider Monkey
Jul-22	National Bank Lifts PT on B2Gold (BTG) to C$8 From C$7.75, Keeps an Outperform Rating BTG Insider Monkey
Jul-22	Itau BBA Downgrades Banco Bradesco S.A. (BBD) to Market Perform From Outperform BBD Insider Monkey
Jul-22	Jefferies Downgrades Clarivate (CLVT) to Hold From Buy, Brings PT Down to $4.50 CLVT Insider Monkey
Jul-22	RBC Capital Remains Bullish on New Gold (NGD) NGD Insider Monkey
Jul-22	Barclays Maintains a Sell Rating on Coty (COTY) With a $4.50 PT COTY Insider Monkey
Jul-22	JPMorgan Lowers PT on Nokia (NOK) to EUR 5.60 From EUR 6.05, Keeps an Overweight Rating NOK Insider Monkey
Jul-22	Wedbush Maintains a Buy on Playtika Holding (PLTK), Sets a Price Target of $11.50 PLTK Insider Monkey
Jul-20	Offerpad Solutions (OPAD) Announces Strategic Partnership with Auction.com OPAD Insider Monkey
Jul-20	Viomi Technology (VIOT) Announces Approval of a Special Dividend VIOT Insider Monkey
Jul-20	JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK) PROK Insider Monkey
Jul-20	Above Food Ingredients (ABVE) Announces Acquisition of Palm Global Technologies ABVE Insider Monkey
Jul-20	H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target VOR Insider Monkey
Jul-20	H.C. Wainwright Reiterates a Buy Rating on Lexicon Pharmaceuticals (LXRX) LXRX Insider Monkey
Jul-20	BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT PRME Insider Monkey
Jul-20	Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating NMRA Insider Monkey
Jul-20	KBW Maintains a Hold on Opendoor Technologies (OPEN) OPEN Insider Monkey
Jul-20	MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange MEIP Insider Monkey
Jul-20	Morgan Stanley Lifts PT on T-Mobile US (TMUS) to $280 from $265, Keeps Overweight Rating TMUS Insider Monkey
Jul-20	William Blair Maintains a Buy Rating on Palo Alto Networks (PANW) PANW Insider Monkey
Jul-20	Morgan Stanley Raises PT on RTX Corporation (RTX) to $165 from $135, Keeps Overweight Rating RTX Insider Monkey
Jul-20	Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT ABBV Insider Monkey
Jul-20	China Galaxy International Downgrades PT on PDD Holdings (PDD) from $164 to $112 PDD Insider Monkey
Jul-20	Wells Fargo Reiterates a Buy Rating on The Progressive Corporation (PGR), Retains $333 PT PGR Insider Monkey
Jul-20	Oppenheimer Remains Bullish on Costco (COST) COST Insider Monkey
Jul-20	Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi TMO Insider Monkey
Jul-20	Morgan Stanley Lifts PT on The Charles Schwab Corporation (SCHW) to $117, Keeps Overweight Rating SCHW Insider Monkey
Jul-20	TD Cowen Maintains a Buy on ServiceNow (NOW), Keeps the PT at $1,150 NOW Insider Monkey
Jul-18	BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510 GSK Insider Monkey
Jul-18	Energy Transfer LP (ET) Gets Initiated With a New Buy Rating at TD Cowen ET Insider Monkey
Jul-18	Scotiabank Raises PT on Suncor Energy (SU) to C$60 From C$57, Keeps Sector Perform Rating SU Insider Monkey
Jul-18	RBC Capital Reiterates a Hold Rating on BP p.l.c. (BP), Sets a £4.50 Price Target BP Insider Monkey
Jul-18	BMO Capital Maintains a Buy on Canadian Natural Resources (CNQ) With a C$56 PT CNQ Insider Monkey
Jul-18	BofA Raises PT on Truist Financial (TFC) to $50 From $46, Keeps a Buy Rating TFC Insider Monkey
Jul-18	BofA Lifts PT on US Bancorp (USB) to $54 From $49, Maintains a Buy Rating USB Insider Monkey
Jul-18	TD Cowen Reiterates a Buy Rating on Verizon Communications (VZ) With a $50 PT VZ Insider Monkey
Jul-18	Stifel Nicolaus Lowers Price Target on Schlumberger Limited (SLB) to $52, Keeps a Buy Rating SLB Insider Monkey
Jul-18	Morgan Stanley Maintains a Sell Rating on Bristol-Myers Squibb (BMY), Sets a $34 PT BMY Insider Monkey
Jul-18	Morgan Stanley Lifts PT on AT&T (T) to $32, Keeps an Overweight Rating T Insider Monkey
Jul-18	Morgan Stanley Maintains a Hold on Pfizer (PFE) PFE Insider Monkey
Jul-18	Barclays Says Bank of America's (BAC) Q2 Report "Positive" for Mastercard and Visa BAC Insider Monkey
Jul-16	Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) INMD Insider Monkey
Jul-16	Truist Financial Remains Bullish on AdaptHealth (AHCO) AHCO Insider Monkey
Jul-16	ZimVie (ZIMV) Announces the Launch of its RealGUIDE Software Suite and Implant Concierge Service in Japan ZIMV Insider Monkey
Jul-16	Needham Downgrades CONMED Corporation (CNMD) to Hold from Buy CNMD Insider Monkey
Jul-16	Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating BVS Insider Monkey
Jul-16	Avanos Medical (AVNS) Appoints Camille Chang Gilmore as SVP and Chief Human Resources Officer AVNS Insider Monkey
Jul-16	Evercore ISI Maintains a Buy on Enovis Corporation (ENOV) With a $46 PT ENOV Insider Monkey
Jul-16	RBC Capital Maintains a Buy Rating on QuidelOrtho Corporation (QDEL), Sets a $60 PT QDEL Insider Monkey
Jul-16	Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT LIVN Insider Monkey
Jul-16	Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) ZBH Insider Monkey
Jul-16	Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs RVMD Insider Monkey
Jul-16	Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group ALVO Insider Monkey
Jul-16	Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) PCVX Insider Monkey
Jul-16	H.C. Wainwright Reiterates a Buy Rating on Viking Therapeutics (VKTX), Sets a $102 PT VKTX Insider Monkey
Jul-16	William Blair Maintains a Buy on Ultragenyx Pharmaceutical (RARE) RARE Insider Monkey
Jul-16	BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating APGE Insider Monkey
Jul-16	Goldman Sachs Resumes Coverage of Immunovant (IMVT) with a Hold Rating IMVT Insider Monkey
Jul-16	Crinetics Pharmaceuticals (CRNX) Gets Initiated With a Hold Rating at Goldman Sachs CRNX Insider Monkey
Jul-16	BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target DNLI Insider Monkey
Jul-16	Morgan Stanley Maintains a Buy on WeRide (WRD), Sets a $13 PT WRD Insider Monkey
Jul-16	Beam Therapeutics (BEAM) Announces Acquisition of an Early-Stage Life Sciences Company BEAM Insider Monkey
Jul-16	Jefferies Remains Bullish on NewAmsterdam Pharma (NAMS) NAMS Insider Monkey
Jul-13	BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT NVAX Insider Monkey
Jul-13	Citizens JMP Slashes PT on PRA Group (PRAA) to $23, Keeps an Outperform Rating PRAA Insider Monkey
Jul-13	Canaccord Lifts PT on EZCORP (EZPW) to $25, Keeps a Buy Rating EZPW Insider Monkey
Jul-13	BofA Maintains a Buy Rating on PG&E Corporation (PCG), Sets a $24 PT PCG Insider Monkey
Jul-13	Deluxe Corporation (DLX) Announces Strategic Partnership With Chargent DLX Insider Monkey
Jul-13	Craig-Hallum Remains Bullish on Photronics (PLAB) PLAB Insider Monkey
Jul-13	Cantor Fitzgerald Reiterates a Hold Rating on Acadia Healthcare Company (ACHC) ACHC Insider Monkey
Jul-13	BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating EMBC Insider Monkey
Jul-13	UBS Lifts Price Target on LexinFintech Holdings (LX) to $13.60 from $9.60 LX Insider Monkey
Jul-13	JPMorgan Lowers PT on Criteo S.A. (CRTO) to $27 from $39, Keeps a Neutral Rating CRTO Insider Monkey
Jul-13	Morgan Stanley Downgrades Centene Corporation (CNC) to Equal Weight From Overweight CNC Insider Monkey
Jul-13	Roth Capital Remains Bullish on DoubleDown Interactive (DDI) DDI Insider Monkey
Jul-13	Navios Maritime Partners (NMM) Announces $35.5 Million Sale of a 2009-Built Containership NMM Insider Monkey
Jul-11	Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT MNKD Insider Monkey
Jul-11	Organon & Co. (OGN) Announces American Academy of Dermatology's Strong Recommendation for VTAMA Cream OGN Insider Monkey
Jul-11	Leerink Partners Remains Bullish on GoodRx Holdings (GDRX) GDRX Insider Monkey
Jul-11	Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension AMRX Insider Monkey
Jul-11	Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel BHC Insider Monkey
Jul-11	BofA Remains a Hold on Teladoc Health (TDOC), Sets a PT of $8.75 TDOC Insider Monkey
Jul-11	Clover Health Investments (CLOV) Announces Launch of a New Community-Based Pharmacy Pilot Program across New Jersey CLOV Insider Monkey

Noor Ul Ain Rehman

Recent Articles by Noor Ul Ain Rehman

Upgrade your FINVIZ experience